世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000034689

個別化ゲノム医療市場-2032年までの予測

Fatpos Global

Genomics Personalized Health Market -Forecasts to 2032

発刊日 2022/11

言語英語

体裁Word-PDF

ライセンス/価格

0000034689

Excel
Single
Multi
Global

※170-350ページ
※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

このレポートでは市場を、materialの種類別、厚さ別、用途別、透明性別、最終用途業種別、地域別に分類しています。個別化ゲノム医療市場は、2022 年の 85 億 9000 万ドルから 3032 年までに 314 億 6000 万ドルに成長し、予測期間中のCAGRは 12.5%と予想されます。

さらに、この調査には、需要と供給のリスク、市場の魅力、BPS 分析、および業界の成長推進要因と阻害要因の詳細な調査のためのポーターの 5 つの力モデルが含まれています。このレポートは、世界の個別化ゲノム医療市場における主要な競合他社の企業プロファイルと、現在の競争環境に関する情報を提供します。

・ Thermo Fisher Scientific Inc.
・ Illumina Inc.
・ Vikor Scientific
・ Roche Holding AG
・ Qiagen
・ Quantgene
・ Bio-Rad Laboratories Inc.
・ Lonza Group AG
・ ARCA biopharma
・ Invitae Corporation
・ Genetic Technologies Limited
・ Interleukin Genetics Inc.
・ Eastern Biotech and Life Sciences
・ DNA Genotek Inc.
・ XCode Life Sciences Private Limited.
・ その他の著名なプレイヤー

レポート詳細

目次

CONTENTS

1 Executive Summary

2 Global Genomics Personalized Health Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms

3 Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation

4 Average Pricing Analysis

5 Macro-Economic Indicators

6 Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends

7 Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix

8 Recent Development, Policies & Regulatory Landscape

9 Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis

10 Global Genomics Personalized Health Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological

11 Global Genomics Personalized Health Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

12 Global Oncology Pharmaceuticals Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Type: Market Share (2020-2030F)
12.2.1. Chemotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Targeted Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Immunotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Hormonal Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Indication: Market Share (2020-2030F)
12.3.1. Lung Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Stomach Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Breast Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. Prostate Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By End user: Market Share (2020-2030F)
12.4.1. Specialized cancer treatment centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Hospitals Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.3. Retail Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

13 Company Profile
Thermo Fisher Scientific Inc.
Illumina Inc.
Vikor Scientific
Roche Holding AG
Qiagen
Quantgene
Bio-Rad Laboratories Inc.
Lonza Group AG
ARCA biopharma
Invitae Corporation
Genetic Technologies Limited
Interleukin Genetics Inc.
Eastern Biotech and Life Sciences
DNA Genotek Inc.
XCode Life Sciences Private Limited.
Other Prominent Players

14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

この商品のレポートナンバー

0000034689

TOP